Publikasi Scopus 926 artikel (Per 14 Maret 2022)

Fujiwara T., Hoshide S., Tomitani N., Cheng H.-M., Soenarta A.A., Turana Y., Chen C.-H., Minh H.V., Sogunuru G.P., Tay J.C., Wang T.-D., Chia Y.-C., Verma N., Li Y., Wang J.-G., Kario K.
57212076752;6603859769;57189644362;57026688600;6507634613;56083326000;7501963868;57211946145;26428524900;24330212600;7405566618;57204080905;7102496979;55931488300;57211730247;7102633390;
Clinical significance of nocturnal home blood pressure monitoring and nocturnal hypertension in Asia
2021
Journal of Clinical Hypertension
23
3
457
466
4
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Center for Evidence-Based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia; Faculty of Medical and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue, Viet Nam; Department of Cardiology, MIOT International Hospital, Chennai, India; College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Department of Physiology, King George's Medical University, Lucknow, India; Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Fujiwara, T., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan; Hoshide, S., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan; Tomitani, N., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan; Cheng, H.-M., Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan, Center for Evidence-Based Medicine, Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan; Soenarta, A.A., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Jakarta, Indonesia; Turana, Y., Faculty of Medical and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Chen, C.-H., Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, Institute of Public Health and Community Medicine Research Center, National Yang-Ming University School of Medicine, Taipei, Taiwan; Minh, H.V., Department of Internal Medicine, University of Medicine and Pharmacy, Hue University, Hue, Viet Nam; Sogunuru, G.P., Department of Cardiology, MIOT International Hospital, Chennai, India, College of Medical Sciences, Kathmandu University, Bharatpur, Nepal; Tay, J.C., Department of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore; Wang, T.-D., Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan, Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Chia, Y.-C., Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Bandar Sunway, Malaysia, Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; Verma, N., Department of Physiology, King George's Medical University, Lucknow, India; Li, Y., Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Wang, J.-G., Department of Hypertension, Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Kario, K., Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan
Nocturnal home blood pressure (BP) monitoring has been used in clinical practice for ~20 years. The authors recently showed that nocturnal systolic BP (SBP) measured by a home BP monitoring (HBPM) device in a Japanese general practice population was a significant predictor of incident cardiovascular disease (CVD) events, independent of office and morning home SBP levels, and that masked nocturnal hypertension obtained by HBPM (defined as nocturnal home BP ≥ 120/70 mmHg and average morning and evening BP < 135/85 mmHg) was associated with an increased risk of CVD events compared with controlled BP (nocturnal home BP < 120/70 mmHg and average morning and evening BP < 135/85 mmHg). This evidence revealed that (a) it is feasible to use a nocturnal HBPM device for monitoring nocturnal BP levels, and (b) such a device may offer an alternative to ambulatory BP monitoring, which has been the gold standard for the measurement of nocturnal BP. However, many unresolved clinical problems remain, such as the measurement schedule and conditions for the use of nocturnal HBPM. Further investigation of the measurement of nocturnal BP using an HBPM device and assessments of the prognostic value are thus warranted. Asians are at high risk of developing nocturnal hypertension due to high salt sensitivity and salt intake, and the precise management of their nocturnal BP levels is important. Information and communication technology-based monitoring devices are expected to facilitate the management of nocturnal hypertension in Asian populations. © 2021 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC
Asia; blood pressure; blood pressure monitoring; nocturnal home blood pressure; nocturnal hypertension
albumin to creatinine ratio; Asia; blood pressure measurement; blood pressure monitoring; blood pressure regulation; cardiovascular disease; clinical feature; clinical research; diagnostic value; feasibility study; general practice; gold standard; high risk population; human; hypertension; Japanese (people); medical informatics; nocturnal home blood pressure monitoring; nocturnal hypertension; organ injury; pathophysiology; prognosis; Review; salt intake; systolic blood pressure; target organ damage; blood pressure; blood pressure monitoring; hypertension; masked hypertension; Asia; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Humans; Hypertension; Masked Hypertension
John Wiley and Sons Inc
15246175
33591641
Review
Q2
909
5078